Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line. 1994

F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
Department of Biochemistry and Molecular Biology, University of Bergen.

Human glioblastoma cells (A172) were found to concomitantly express PDGF-BB and PDGF beta-receptors. The receptors were constitutively autophosphorylated in the absence of exogenous ligand, suggesting the presence of an autocrine PDGF pathway. Neutralizing PDGF antibodies as well as suramin inhibited the autonomous PDGF receptor tyrosine kinase activity and resulted in up-regulation of receptor protein. The interruption of the autocrine loop by the PDGF antibodies reversed the transformed phenotype of the glioblastoma cell, as determined by (1) diminished DNA synthesis, (2) inhibition of tumor colony growth, and (3) reversion of the transformed morphology of the tumor cells. The PDGF antibodies showed no effect on the DNA synthesis of another glioblastoma cells line (U-343MGa 31L) or on Ki-ras-transformed fibroblasts. The present study demonstrates an endogenously activated PDGF pathway in a spontaneous human glioblastoma cell line. Furthermore, we provide evidence that the autocrine PDGF pathway drives the transformed phenotype of the tumor cells, a process that can be blocked by extracellular antagonists.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
July 1992, Oncogene,
F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
July 1981, Proceedings of the National Academy of Sciences of the United States of America,
F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
February 1990, Journal of neuro-oncology,
F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
December 1993, Molecular and cellular biology,
F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
July 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
October 1991, Cancer research,
F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
May 1996, Journal of neurosurgery,
F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
January 1989, Pediatric neurology,
F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
January 1994, Noshuyo byori = Brain tumor pathology,
F S Vassbotn, and A Ostman, and N Langeland, and H Holmsen, and B Westermark, and C H Heldin, and M Nistér
August 1991, In vitro cellular & developmental biology : journal of the Tissue Culture Association,
Copied contents to your clipboard!